Haemophilia protects against ischaemic heart disease: a study of risk factors
- 1 August 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (4), 525-530
- https://doi.org/10.1111/j.1365-2141.1990.tb07793.x
Abstract
Summary. We previously reported that mortality due to ischaemic heart disease was lower in haemophilia patients than in the general male population. To support the hypothesis that this could be attributed to a protective effect of the clotting defect in haemophilia and not to differences in cardiovascular risk factors, we performed a second study. We examined 95 haemophilia patients for the presence of major risk factors for ischaemic heart disease and compared their risk factor profile with the data of epidemiologic surveys of the general Dutch population. Haemophilia patients had on average higher blood pressures than the comparison population, were more often hypertensive and used antihypertensive drugs twice as often. The mean serum cholesterol level of the patients was markedly lower than in the comparison population (4.8 versus 5.6 mmol/1. 9 5% confidence interval of the difference: 0.5–1.1 Mmmol/l). The risk factors were weighted into one theoretical risk ratio for ischaemic heart disease by application of logistic regression coefficients. The theoretical risk ratio based on the risk factor profile was 0.78. This risk ratio can only explain a moderate reduction in the, incidence of ischaemic heart disease, much smaller than the mortality ratio of 0.20 we reported previously. Therefore these data support the hypothesis of a direct protective effect of haemophilia on the development of ischaemic heart disease.This publication has 22 references indexed in Scilit:
- Mortality and causes of death in Dutch haemophiliacs, 1973–86British Journal of Haematology, 1989
- Serum cholesterol and risk of cancer in a cohort of 39,000 men and womenJournal of Clinical Epidemiology, 1988
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Prognosis in Treated HypertensionActa Medica Scandinavica, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. Experience of an international collaborative groupPublished by American Medical Association (AMA) ,1982
- A DOUBLE-BLIND TRIAL TO ASSESS LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- HIGH-DENSITY LIPOPROTEIN AND CORONARY RISK FACTORS IN NORMAL MENThe Lancet, 1979
- A multivariate analysis of the risk of coronary heart disease in FraminghamJournal of Chronic Diseases, 1967